Ascending to a UTI vaccine?
作者信息
Clarkson Sheilagh
出版信息
Nat Rev Microbiol. 2004 Feb;2(2):90. doi: 10.1038/nrmicro835.
PMID:15040255
Abstract
摘要
相似文献
1
Ascending to a UTI vaccine?朝着一种泌尿道感染疫苗迈进？
Nat Rev Microbiol. 2004 Feb;2(2):90. doi: 10.1038/nrmicro835.
2
Vaccination to Protect Against Proteus mirabilis Challenge Utilizing the Ascending Model of Urinary Tract Infection.利用上行性尿路感染模型接种疫苗以抵御奇异变形杆菌攻击
Methods Mol Biol. 2019;2021:201-215. doi: 10.1007/978-1-4939-9601-8_18.
3
Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.天然鞭毛蛋白不能保护小鼠免受实验性奇异变形杆菌上行性尿路感染的侵害，并且会中和MrpA菌毛蛋白的保护作用。
Antonie Van Leeuwenhoek. 2014 Jun;105(6):1139-48. doi: 10.1007/s10482-014-0175-7. Epub 2014 Apr 27.
4
[Protective effect of coli-proteus vaccine in an experimental animal model].[大肠杆菌-变形杆菌疫苗在实验动物模型中的保护作用]
Cesk Farm. 1980 May;29(3-4):95-9.
5
Vaccines for Proteus mirabilis in urinary tract infection.用于尿路感染的奇异变形杆菌疫苗。
Int J Antimicrob Agents. 2002 Jun;19(6):461-5. doi: 10.1016/s0924-8579(02)00102-4.
6
Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.开发一种鼻内疫苗以预防奇异变形杆菌引起的尿路感染。
Infect Immun. 2004 Jan;72(1):66-75. doi: 10.1128/IAI.72.1.66-75.2004.
7
Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis.将MrpH菌毛粘附素结合结构域与霍乱毒素A2结构域进行翻译融合，并与霍乱毒素B亚基共表达，用作鼻内疫苗以预防奇异变形杆菌引起的实验性尿路感染。
Infect Immun. 2004 Dec;72(12):7306-10. doi: 10.1128/IAI.72.12.7306-7310.2004.
8
Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.用奇异变形杆菌毒性凝集素（一种体内不依赖溶血素的细胞毒素）进行疫苗接种可预防奇异变形杆菌尿路感染。
Infect Immun. 2009 Feb;77(2):632-41. doi: 10.1128/IAI.01050-08. Epub 2008 Nov 24.
9
Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.用展示奇异变形杆菌MrpA菌毛蛋白锚定形式或分泌形式的重组乳酸乳球菌进行鼻内免疫，可赋予特异性免疫反应，并显著减少小鼠肾脏中的细菌定植。
Microbes Infect. 2007 Jun;9(7):821-8. doi: 10.1016/j.micinf.2007.02.023. Epub 2007 Mar 12.
10
Oral vaccination against Porteus mirabilis.针对奇异变形杆菌的口服疫苗接种。
Br J Exp Pathol. 1976 Aug;57(4):395-9.
Zotero 插件